Relationships between uptake of [68Ga]Ga-DOTA-TATE and absorbed dose in [177Lu]Lu-DOTA-TATE therapy

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2191-219X
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Relationships between uptake of [68Ga]Ga-DOTA-TATE and absorbed dose in [177Lu]Lu-DOTA-TATE therapy ; volume:12 ; number:1 ; day:19 ; month:12 ; year:2022 ; pages:1-15 ; date:12.2022
EJNMMI Research ; 12, Heft 1 (19.12.2022), 1-15, 12.2022

Creator
Stenvall, Anna
Gustafsson, Johan
Larsson, Erik
Roth, Daniel
Sundlöv, Anna
Jönsson, Lena
Hindorf, Cecilia
Ohlsson, Tomas
Sjögreen Gleisner, Katarina
Contributor
SpringerLink (Online service)

DOI
10.1186/s13550-022-00947-2
URN
urn:nbn:de:101:1-2023030121032302861236
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:56 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Stenvall, Anna
  • Gustafsson, Johan
  • Larsson, Erik
  • Roth, Daniel
  • Sundlöv, Anna
  • Jönsson, Lena
  • Hindorf, Cecilia
  • Ohlsson, Tomas
  • Sjögreen Gleisner, Katarina
  • SpringerLink (Online service)

Other Objects (12)

Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC

Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC

Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC

Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC

Inter- and intra-tumoral heterogeneity on [68Ga]Ga-DOTA-TATE/[68Ga]Ga-DOTA-TOC PET/CT predicts response to [177Lu]Lu-DOTA-TATE PRRT in neuroendocrine tumor patients

Inter- and intra-tumoral heterogeneity on [68Ga]Ga-DOTA-TATE/[68Ga]Ga-DOTA-TOC PET/CT predicts response to [177Lu]Lu-DOTA-TATE PRRT in neuroendocrine tumor patients

Prediction of [177Lu]Lu-DOTA-TATE therapy response using the absorbed dose estimated from [177Lu]Lu-DOTA-TATE SPECT/CT in patients with metastatic neuroendocrine tumour

Prediction of [177Lu]Lu-DOTA-TATE therapy response using the absorbed dose estimated from [177Lu]Lu-DOTA-TATE SPECT/CT in patients with metastatic neuroendocrine tumour

Standardized image quality for 68Ga-DOTA-TATE PET/CT

Standardized image quality for 68Ga-DOTA-TATE PET/CT

PET-CT imaging of pulmonary inflammation using [68Ga]Ga-DOTA-TATE

PET-CT imaging of pulmonary inflammation using [68Ga]Ga-DOTA-TATE

Personal dose equivalent H p(0.07) during 68Ga-DOTA-TATE production procedures

Personal dose equivalent H p(0.07) during 68Ga-DOTA-TATE production procedures

Individualisation of radiation protection recommendations for patients treated with [177Lu]Lu-DOTA-TATE

Individualisation of radiation protection recommendations for patients treated with [177Lu]Lu-DOTA-TATE

Radiation exposure and protection advice after [177Lu]Lu-DOTA-TATE therapy in China

Radiation exposure and protection advice after [177Lu]Lu-DOTA-TATE therapy in China

CYP3A4 inhibitors do not influence [68Ga]Ga-DOTA-TATE uptake in liver tissue

CYP3A4 inhibitors do not influence [68Ga]Ga-DOTA-TATE uptake in liver tissue

Enhancing [177Lu]Lu-DOTA-TATE therapeutic efficacy in vitro by combining it with metronomic chemotherapeutics

Enhancing [177Lu]Lu-DOTA-TATE therapeutic efficacy in vitro by combining it with metronomic chemotherapeutics

Radiation exposure assessment of nuclear medicine staff administering [177Lu]Lu-DOTA-TATE with active and passive dosimetry

Radiation exposure assessment of nuclear medicine staff administering [177Lu]Lu-DOTA-TATE with active and passive dosimetry

Related objects